Alembic Ltd - ALEMBIC Share Price

Sector: Pharmaceuticals | ISIN: INE426A01027
₹ 98.50 (-3.62%) icon28 Feb, 2024, 11:49:56 AM
Open
₹ 102.20
Prev. Close
₹ 102.20
Turnover(lac)
₹ 0.01
Day's High
₹ 103.50
Day's Low
₹ 98.10
52 Wk High
₹ 107.65
52 Wk Low
₹ 55.20
Book Value
₹ 35.10
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 2,529.30
P/E
30.16
EPS
3.39
Div. Yield
2.15

Alembic Ltd Stock View

info icon
Edit Image
Target | 03 Apr, 2023 68 (-33.46%)

Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceu... Read More

Alembic Ltd KEY RATIOS

sector: Realty

  • CMP

    as on 2/28/2024 11:49:56 AM

    ₹ 98.5 -3.70 -3.62
  • Open
  • ₹ 102.2
  • Prev. Close
  • ₹ 102.2
  • Turnover(Lac.)
  • ₹ 682
  • Day's High
  • ₹ 103.5
  • Day's Low
  • ₹ 98.1
  • 52 Week's High
  • ₹ 107.65
  • 52 Week's Low
  • ₹ 55.2
  • Book Value
  • ₹ 35.1
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 2,529.3
  • P/E
  • 30.16
  • EPS
  • 3.39
  • Divi. Yield
  • 2.15

Alembic Ltd Corporate Actions

05 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Feb , 2024

12:00 AM

30 Oct , 2023

12:00 AM

30 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Jun , 2023

12:00 AM

AGM

Announcement date: 20 Jun , 2023

View Details

02 Aug , 2023

12:00 AM

12 May , 2023

12:00 AM

Dividend

Dividend amount: 2.2
Announcement date: 12 May , 2023

View Details

04 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

Alembic Ltd News and Update

Image not found
  • 1 day ago |
  • 12:13 AM

A press release issued by One97 Communications Ltd highlighted the appointment of several new members to the PPBL Board

Image not found
  • IIFL News Service |
  • 23 February, 2024 |
  • 12:07 AM
Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Alembic Ltd SHAREHOLDING SNAPSHOT
28 February , 2024 | 12:09 PM

PROMOTER - TOTAL70.88%

Indian: 70.88%

Foreign: 0%

NON-PROMOTER - TOTAL 29.12%

Institutions: 0.95%

Non-Institutions: 28.17%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Alembic Ltd FINANCIALS

Alembic Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Alembic Ltd

  • Chirayu R Amin
  • Chairman (Non-Executive)
  • Malika C Amin
  • Managing Director & CEO
  • C P Buch
  • Independent Director
  • Udit Amin
  • Director
  • Abhijit Joshi
  • Director
  • Sameer Khera
  • Independent Director
  • Drigesh Mittal
  • Company Sec. & Compli. Officer
  • Rati Desai
  • Independent Director
  • Mayank Amin
  • Independent Director
  • Girish Hirode
  • Independent Director

Summary

Alembic Ltd is one of the Indias most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in three lines of business, manufacture of Bulk Drugs, Real Estate and Power Generation through Windmills and Co-gen Power Plant which is presently used for captive consumption for the operation of the Bulk Drugs Manufacturing plant at Vadodara. The Company has been dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.The company is a ISO-9002 and ISO-14001 certified company with manufacturing practices and facilities that conform to WHO-GMP guidelines. They manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. They are having their manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh.Alembic Ltd was incorporated in the year 1907 with the name Alembic Chemical Works Co Ltd in Vadodara to manufacture tinctures and alcohol. They Started to manufacture cough syrup, vitamins, tonics and sulphur durgs in the year 1940. In the year 1961, they inaugrated the Pencillin Palnt. In the year 1968, they started to manufacture Streptomycin.In the 1971, they manufactured Erythromycin using expertise from Eli Lilly, USA and in the year 1972, they launched Althrocin, a brand of Erythromycin. In year 1997, Althrocin become top selling brand in India. In the year 2001, they started to manufacture Cephalosporin C. In... Read More


Reports by Alembic Ltd


Reports by Alembic Ltd

Company FAQ

No Record Found